We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Catco Reinsurance Opportunities Fund Limited | LSE:CAT | London | Ordinary Share | BMG1961Q3242 | ORD USD0.00013716 (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 25.00 | 14.00 | 36.00 | 25.00 | 25.00 | 25.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Unit Inv Tr, Closed-end Mgmt | 6.33M | 5.44M | 3.6440 | 6.86 | 37.33M |
FORM 38.5 DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS (Rule 38.5 of the City Code on Takeovers and Mergers) 1. KEY INFORMATION Name of exempt principal J.P. Morgan Securities Ltd. trader Company dealt in Cambridge Antibody Technology Group Plc Class of relevant security Ordinary Shares to which the dealings being disclosed relate (Note 1) Date of dealing 15 May 2006 2. DEALINGS (Note 2) (a) Purchases and sales Total number of Highest price paid Lowest price paid (Note securities purchased (Note 3) 3) 20,000 12.976 GBP 12.976 GBP Total number of Highest price received Lowest price received securities sold (Note 3) (Note 3) 20,000 12.98 GBP 12.96 GBP (b) Derivatives transactions (other than options) Product Long/short Number of securities Price per unit name, (Note 4) (Note 5) (Note 3) e.g. CFD (c) Options transactions in respect of existing securities (i) Writing, selling, purchasing or varying Product Writing, Number of Exerci Type, Expiry Option name, selling, securities se e.g. date money e.g. call purchasing to which Price American paid/rece option , varying the option , ived per etc. relates European unit (Note 5) etc. (Note 3) (ii) Exercising Product name, e.g. call Number of securities Exercise price per unit option (Note 3) 3. OTHER INFORMATION Agreements, arrangements or understandings relating to options or derivatives Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. Date of disclosure 16 May 2006 Contact name Michael Kirwan Telephone number 020 7325 1413 Name of offeree/offeror with which Cambridge Antibody Technology connected Group Plc Nature of connection (Note 6) 2 Notes The Notes on Form 38.5 can be viewed on the Takeover Panels website at www.thetakeoverpanel.org.uk
1 Year Catco Reinsurance Opport... Chart |
1 Month Catco Reinsurance Opport... Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions